Clinical Trial

« Back to List

GYN 26

Posted by: James A. Williams, Jr., MD, Principal Investigator | Posted Date: November 29, 2010

Status: HOLD - IIT
Research Hotline: 803-461-3708

Details: A Phase I/II Study of the Combination of Pazopanib and Liposomal Doxorubicin (Doxil) in Patients with Advanced Relapsed Platinum-Sensitive or Platinum-Resistant Ovarian, Fallopian Tube or Primary Peritoneal Adenocarcinoma.

This clinical trial is being offered at the following location: South Carolina Oncology Associates


Bookmark and Share